Home ›
Organizations ›
RX-360 INTERNATIONAL PHARMACEUTICAL SUPPLY CHAIN CONSORTIUM
RX-360 INTERNATIONAL PHARMACEUTICAL SUPPLY CHAIN CONSORTIUM
PA · Employment · EIN 452410498
9
Executives Disclosed
$5.0M
Annual Revenue
$5.8M
Total Assets
1.1:1
Internal Pay Ratio
RX-360 INTERNATIONAL PHARMACEUTICAL SUPPLY CHAIN CONSORTIUM has 9 executives with disclosed compensation. The highest-paid executive, James Fries (CEO), received peak total compensation of $321,710. The sector average for Employment executives is $118K.
Top Executive Compensation Over Time
Executive Compensation
| Name | Title | Peak Comp. | Latest Comp. | Years | vs. Household |
|---|---|---|---|---|---|
| James Fries | CEO | $322K | $322K | 2024–2024 | 4.3x |
| Jim Fries | CEO | $306K | $306K | 2018–2023 | 4.1x |
| Mark Paxton Thru 102017 | CEO | $301K | $301K | 2017–2017 | 4x |
| Benjamin Mills | SENIOR DIRECTOR OF OPERATIONS | $180K | $180K | 2023–2024 | 2.4x |
| Kendall Feshuk | MANAGER, MEMBER MANAGEMENT | $152K | $152K | 2024–2024 | 2x |
| Kristen Farr | SENIOR DIRECTOR OF FINANCE | $132K | $0 | 2023–2023 | 1.8x |
| Jaye Green | HEAD OF AUDIT OPERATIONS | $125K | $0 | 2022–2022 | 1.7x |
| Gordon Curtis | SENIOR DIRECTOR OF FINANCE | $115K | $0 | 2024–2024 | 1.5x |
| Mark Paxton | CEO | $21K | $0 | 2016–2016 | 0.3x |
Annual Summary
| Year | Executives | Avg. Comp. | Highest Comp. | Total Payroll |
|---|---|---|---|---|
| 2016 | 1 | $0 | $0 | $0 |
| 2017 | 1 | $301K | $301K | $301K |
| 2018 | 1 | $180K | $180K | $180K |
| 2019 | 1 | $278K | $278K | $278K |
| 2020 | 1 | $247K | $247K | $247K |
| 2021 | 1 | $285K | $285K | $285K |
| 2022 | 2 | $294K | $294K | $294K |
| 2023 | 3 | $306K | $306K | $306K |
| 2024 | 4 | $218K | $322K | $653K |
Email Alerts
Get notified about RX-360 INTERNATIONAL PHARMACEUTICAL SUPPLY CHAIN CONSORTIUM
Get an email when a new IRS Form 990 filing is posted that includes this organization. We send a confirmation link first - we don't add you to any other list.